701
Participants
Start Date
July 23, 2017
Primary Completion Date
February 12, 2020
Study Completion Date
January 16, 2026
Nivolumab
Specified dose on specified day
Cabozantinib
Specified dose on specified days
Sunitinib
Specified dose on specified days.
Ipilimumab
Specified dose on specified days
Local Institution - 0002, North Ryde
Local Institution - 0048, Ciudad Autonoma de Buenos Aire
Local Institution - 0138, CABA
Local Institution - 0008, Sydney
Local Institution - 0009, Sydney
Local Institution - 0073, Westmead
Local Institution - 0005, Malvern
Local Institution - 0047, San Miguel de Tucumán
Local Institution - 0006, Herston
Local Institution - 0129, South Brisbane
Local Institution - 0001, Southport
Local Institution - 0050, Córdoba
Local Institution - 0004, Elizabeth Vale
Local Institution - 0007, Doubleview
Local Institution - 0114, Viedma
Local Institution - 0017, New York
Local Institution - 0116, Mexico City
Local Institution - 0115, Tlalpan
Local Institution - 0040, Buffalo
Local Institution - 0135, Allentown
Local Institution - 0097, Denizli
Local Institution - 0052, Milan
Local Institution - 0095, Edirne
Local Institution - 0131, Norfolk
Local Institution - 0051, Pavia
Local Institution - 0147, Pavia
Local Institution - 0121, Madrid
Local Institution - 0120, Madrid
Local Institution - 0086, Newnan
Local Institution - 0127, Athens
Local Institution - 0146, Istanbul
Local Institution - 0077, Daphne
Local Institution - 0105, Nashville
Local Institution - 0144, Santander
Local Institution - 0124, Seville
Local Institution - 0070, Kfar Saba
Local Institution - 0108, Zapopan
Local Institution - 0117, Essen
Local Institution - 0123, Valencia
Local Institution - 0091, Fort Wayne
Local Institution - 0071, Petah Tikva
Local Institution - 0013, Aachen
Local Institution - 0054, Arezzo
Local Institution - 0069, Ramat Gan
Local Institution - 0016, Bonn
Local Institution - 0042, Zion
Local Institution - 0036, Chicago
Local Institution - 0035, St Louis
Local Institution - 0065, Monterrey
Local Institution - 0143, Monterrey
Local Institution - 0106, Kansas City
Local Institution - 0064, Monterrey
Local Institution - 0087, Wichita
Local Institution - 0011, Tübingen
Local Institution - 0078, Sherman
Local Institution - 0075, Dallas
Local Institution - 0063, Querétaro City
Local Institution - 0068, Houston
Local Institution - 0080, Austin
Local Institution - 0103, Aurora
Local Institution - 0055, Napoli
Local Institution - 0010, München
Local Institution - 0044, Goodyear
Local Institution - 0130, Bydgoszcz
Local Institution - 0102, Las Vegas
Local Institution - 0090, Redondo Beach
Local Institution - 0093, Los Angeles
Local Institution - 0014, Nuremberg
Local Institution - 0133, Bakersfield
Local Institution - 0088, San Luis Obispo
Central Coast Medical Oncology Corporation, Santa Maria
Local Institution - 0136, Mérida
Local Institution - 0067, Portland
Local Institution - 0020, Moscow
Local Institution - 0099, Saint Petersburg
Local Institution - 0022, Craiova
Local Institution - 0021, Cluj-Napoca
Local Institution - 0158, Bunkyo-ku
Local Institution - 0151, Bunkyo-ku
Local Institution - 0072, Haifa
Local Institution - 0155, Hidaka-shi
Local Institution - 0170, Osaka
Local Institution - 0160, Osakasayamashi
Local Institution - 0168, Kobe
Local Institution - 0169, Okayama
Local Institution - 0153, Tokushima
Local Institution - 0045, Santiago
Local Institution - 0162, Nagasaki
Local Institution - 0150, Niigata
Local Institution - 0165, Yamagata
Local Institution - 0132, Tucson
Local Institution - 0113, Boston
Local Institution - 0037, Boston
Local Institution - 0046, CABA
Local Institution - 0049, Córdoba
Local Institution - 0057, Belo Horizonte
Local Institution - 0119, Ijuí
Local Institution - 0056, Porto Alegre
Local Institution - 0060, Porto Alegre
Local Institution - 0058, Barretos
Local Institution - 0066, Rio de Janeiro
Local Institution - 0074, São Paulo
Local Institution - 0061, São Paulo
Local Institution - 0034, Hradec Králové
Local Institution - 0033, Olomouc
Local Institution - 0023, Jena
Local Institution - 0082, Athens
Local Institution - 0083, Thessaloniki
Local Institution - 0053, Padua
Local Institution - 0172, Terni
Local Institution - 0148, Akita
Local Institution - 0156, Hirosaki
Local Institution - 0164, Sapporo
Local Institution - 0157, Sapporo
Local Institution - 0159, Morioka
Local Institution - 0171, Yokohama
Local Institution - 0166, Yokohama
Local Institution - 0163, Suita-shi
Local Institution - 0154, Osaka
Local Institution - 0152, Adachi-ku
Local Institution - 0173, Minato-ku
Local Institution - 0167, Chiba
Local Institution - 0161, Fukuoka
Local Institution - 0149, Tokyo
Local Institution - 0062, Mexico City
Local Institution - 0084, Biała Podlaska
Local Institution - 0085, Gdansk
Local Institution - 0125, Barcelona
Local Institution - 0107, Ankara
Local Institution - 0139, Ankara
Local Institution - 0094, Ankara
Local Institution - 0096, Antalya
Local Institution - 0111, London
Local Institution - 0109, Manchester
Local Institution - 0140, Truro
Lead Sponsor
Collaborators (2)
Exelixis
INDUSTRY
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY